BENZIMIDAZOLONE DERIVATIVES, AND ANALOGUES THEREOF, AS IL-17 MODULATORS
A series of substituted benzimidazol-2-one derivatives, and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders. Une série de dérivés de benzimidaz...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
18.06.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A series of substituted benzimidazol-2-one derivatives, and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.
Une série de dérivés de benzimidazole-2-one substitués, et des analogues de ceux-ci, sont de puissants modulateurs de l'activité de l'IL-17 humaine, et sont par conséquent utiles dans le traitement et/ou la prévention de diverses maladies humaines, y compris des troubles inflammatoires et auto-immuns. |
---|---|
AbstractList | A series of substituted benzimidazol-2-one derivatives, and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.
Une série de dérivés de benzimidazole-2-one substitués, et des analogues de ceux-ci, sont de puissants modulateurs de l'activité de l'IL-17 humaine, et sont par conséquent utiles dans le traitement et/ou la prévention de diverses maladies humaines, y compris des troubles inflammatoires et auto-immuns. |
Author | LECOMTE, Fabien Claude SELBY, Matthew Duncan |
Author_xml | – fullname: SELBY, Matthew Duncan – fullname: LECOMTE, Fabien Claude |
BookMark | eNrjYmDJy89L5WRwd3L1i_L09XRxjPL38fdzVXBxDfIMcwzxDHMN1lFw9HMBYkcff_dQ12CFEA_XIFd_N6BwsIKnj66huYKvv0uoj2OIf1AwDwNrWmJOcSovlOZmUHZzDXH20E0tyI9PLS5ITE7NSy2JD_c3MjAyMAQiEwNHQ2PiVAEAoAUu4w |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | DÉRIVÉS DE BENZIMIDAZOLONE, ET ANALOGUES DE CEUX-CI, EN TANT QUE MODULATEURS D'IL-17 |
ExternalDocumentID | WO2020120140A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2020120140A13 |
IEDL.DBID | EVB |
IngestDate | Fri Sep 06 06:15:07 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2020120140A13 |
Notes | Application Number: WO2019EP82774 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200618&DB=EPODOC&CC=WO&NR=2020120140A1 |
ParticipantIDs | epo_espacenet_WO2020120140A1 |
PublicationCentury | 2000 |
PublicationDate | 20200618 |
PublicationDateYYYYMMDD | 2020-06-18 |
PublicationDate_xml | – month: 06 year: 2020 text: 20200618 day: 18 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | UCB BIOPHARMA SRL |
RelatedCompanies_xml | – name: UCB BIOPHARMA SRL |
Score | 3.2705717 |
Snippet | A series of substituted benzimidazol-2-one derivatives, and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | BENZIMIDAZOLONE DERIVATIVES, AND ANALOGUES THEREOF, AS IL-17 MODULATORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200618&DB=EPODOC&locale=&CC=WO&NR=2020120140A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIKyJ4vrx5r5MKRr0nXSNWPt5tjLaLoWBOmGq_jveymb7mkPCfmAEEJ-d_kldxeAR2MhRGakloo5EhStlakvAveyaYkENXycWUI6OA8Cyxubb9PWtAKfW1-YMk7oTxkcERGVIN6LUl6v_i-xaGlbuX4WH9i0fHWjDm1s2LHkxwhn2u2wIafcaTgO8rZGMCr7NF3SCRu50gEepInEA5t0pV_KalepuKdwOMTx8uIMKmleg2Nn-_daDY4GmydvLG7Qtz6HXpcFMxQ21J5xnwdMocjCJnbUn7DwSbEDisn2eW_MQiXy2IhxF5tDpe-rGlEGnI59O-Kj8AIeXBY5noozmv8twPyd707fuIRqvszTK1DSWM9SosfNjMTmomWJdiLD4ywSPbEIaZJrqO8b6WZ_9y2cyKo0jNLadagWX9_pHargQtyXK_cLDpKDbg |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4QNOKbosYfqEs0PLnIBqz4QMxYO4ZuK2EDCS9kHVtiYiaRGf99rwsoTzy0aXrJpWn63fVre1eA--ZCiLSZGCrWSFC0dqo-CVzLLUPE6OGj1BAywNnzDWfcepm2pyX42MTCFHlCf4rkiIioGPGeF_Z6-X-IRYu3latH8Y5dn8922KX1NTuW_BjhTHtdNuSUW3XLQt5W90eFTNMlnTCRK-3hJptIPLBJT8alLLedin0E-0PUl-XHUEqyKlSszd9rVTjw1lfe2Fyjb3UC_R7zZ2hsqDnjLveZQpGFTcxwMGHBg2L6FIvp8v6YBUrosBHjNnYHysBVNaJ4nI5dM-Sj4BTubBZajoojmv9NwPyNbw-_eQbl7DNLzkFJIj1NiB41UhK1Fm1DdGKZHmcR67FBSINcQG2Xpsvd4luoOKHnzt2B_3oFh1IkH0lpnRqU86_v5BrdcS5uiln8BWSIhmE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BENZIMIDAZOLONE+DERIVATIVES%2C+AND+ANALOGUES+THEREOF%2C+AS+IL-17+MODULATORS&rft.inventor=SELBY%2C+Matthew+Duncan&rft.inventor=LECOMTE%2C+Fabien+Claude&rft.date=2020-06-18&rft.externalDBID=A1&rft.externalDocID=WO2020120140A1 |